Literature DB >> 8972540

Epilepsy and fragile X gene mutations.

G Kluger1, I Böhm, M C Laub, C Waldenmaier.   

Abstract

We used two strategies to investigate a possible link between predisposition for epilepsy and mutations in the fragile X mental retardation-1 gene. The first entailed performing electroencephalography on 14 patients with an amplification in the fragile X mental retardation-1 gene, and the second involved molecular genetic analysis of the fragile X mental retardation-1 gene in 16 children with benign childhood epilepsy with centrotemporal spikes (BECT, Rolandic epilepsy). Fourteen young male patients with fragile X syndrome, verified by a full mutation in exon 1 of the fragile X mental retardation-1 gene, were studied by electroencephalography. In eight boys aged between 4-8 years we observed focal sharp waves, activated by sleep. In six of these patients, partial seizures occurred during sleep. We detected no epileptiform electroencephalographic abnormalities under the age of 4 and over the age of 8. In 16 children with Rolandic epilepsy who were studied for fragile X gene mutations, one boy proved to carry a fragile X premutation. In the waking state electroencephalography of a 5-year-old girl with a premutation in one of her fragile X mental retardation-1 genes, we found groups of generalized spike wave complexes. Our observations suggest a possible impact of the fragile X mental retardation-1 gene mutations on brain maturation and epileptogenesis.

Entities:  

Mesh:

Year:  1996        PMID: 8972540     DOI: 10.1016/s0887-8994(96)00251-2

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  8 in total

Review 1.  The fragile X mental retardation protein in circadian rhythmicity and memory consolidation.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Mol Neurobiol       Date:  2009-02-12       Impact factor: 5.590

2.  Unbalanced Peptidergic Inhibition in Superficial Neocortex Underlies Spike and Wave Seizure Activity.

Authors:  S Hall; M Hunt; A Simon; L G Cunnington; L M Carracedo; I S Schofield; R Forsyth; R D Traub; M A Whittington
Journal:  J Neurosci       Date:  2015-06-24       Impact factor: 6.167

3.  Variations in EEG discharges predict ADHD severity within individual Smith-Lemli-Opitz patients.

Authors:  John M Schreiber; Diane C Lanham; William H Trescher; Susan E Sparks; Christopher A Wassif; Brian S Caffo; Forbes D Porter; Elaine Tierney; Andrea L Gropman; Joshua B Ewen
Journal:  Neurology       Date:  2014-06-11       Impact factor: 9.910

Review 4.  Fragile X syndrome: A review of clinical management.

Authors:  Reymundo Lozano; Atoosa Azarang; Tanaporn Wilaisakditipakorn; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2016-08

5.  Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Front Synaptic Neurosci       Date:  2010-06-07

6.  Seizures in Fragile X Syndrome: Associations and Longitudinal Analysis of a Large Clinic-Based Cohort.

Authors:  Elizabeth Berry-Kravis; Robyn A Filipink; Richard E Frye; Sailaja Golla; Stephanie M Morris; Howard Andrews; Tse-Hwei Choo; Walter E Kaufmann
Journal:  Front Pediatr       Date:  2021-12-30       Impact factor: 3.418

7.  Epileptic Electroencephalography Profile Associates with Attention Problems in Children with Fragile X Syndrome: Review and Case Series.

Authors:  Benjamin Cowley; Svetlana Kirjanen; Juhani Partanen; Maija L Castrén
Journal:  Front Hum Neurosci       Date:  2016-07-12       Impact factor: 3.169

8.  Polysomnographic Findings in Fragile X Syndrome Children with EEG Abnormalities.

Authors:  Marco Carotenuto; Michele Roccella; Francesco Pisani; Sara Matricardi; Alberto Verrotti; Giovanni Farello; Francesca Felicia Operto; Ilaria Bitetti; Francesco Precenzano; Giovanni Messina; Maria Ruberto; Cristiana Ciunfrini; Mariagrazia Riccardi; Eugenio Merolla; Grazia Maria Giovanna Pastorino; Anna Nunzia Polito; Rosa Marotta
Journal:  Behav Neurol       Date:  2019-12-03       Impact factor: 3.342

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.